Entities / Company
Synlait.
New Zealand dairy processing company
- Reports this week
- 0
- Active events
- 0
- Connections
- 11
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Abbott Laboratories is discussing the acquisition of Synlait's Pokeno facility and considering other facilities in New Zealand.Some support2 reports1 development inside
-
An article details how the company Synlait operates in New Zealand, including its assets and majority shareholder structure.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Synlait this week
News at the entities that move Synlait most-
Australian StructuralThe Middle East conflict is driving inflation, with budget outcomes released involving Chalmers and Gallagher.Moves Synlait
-
China OperationalThe European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Moves Synlait
-
Abbott Laboratories TransactionalMarketBeat listed Abbott, Eli Lilly, Pfizer, Gilead, AbbVie, and McKesson as stocks to watch on June 7, 2026.Moves Synlait
-
Christchurch Shared contextPolitical figures addressed the crisis and managed the city response following the 2013 Christchurch earthquake.Moves Synlait
Connections
The 4 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Australian Structural
Australian holds a 65% majority stake in Synlait.
-
China Operational
The competitive relationship is driven by China's strategic push toward achieving food self-sufficiency.
-
Abbott Laboratories Transactional
Abbott discussed acquiring Synlait's Pokeno facility, which was subsequently sold as part of a larger asset divestiture.
-
Christchurch Shared context
The company's assets are observed in the context of the Christchurch geographical area.